Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase EARLY_PHASE1 8Phase 2 6Phase 1 3Phase 3 1Phase 1/2 1

Status

Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Gastrointestinal 1

Conditions

Glioblastoma 1Esophageal Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Ferrosoferric Oxide × Clear all
NCT04900792 2025-12-03

XACT-Fe-GBM-01

University of Iowa

Phase 1 Active not recruiting
17 enrolled
CNS

Glioblastoma

NCT00769093 2017-04-21

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

OHSU Knight Cancer Institute

Phase 1 Terminated
6 enrolled
CNS

Brain Neoplasms

NCT02689401 2016-05-13

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

Dana-Farber Cancer Institute

Phase 1 Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡